Molecular basis of vascular anomalies

被引：81

作者：

Vikkula, M

Boon, LM

Mulliken, JB

Olsen, BR

机构：

[1] Christian de Duve Inst Cellular Pathol, Lab Human Mol Genet, B-1200 Brussels, Belgium

[2] Univ Catholique Louvain, Div Plast Surg, Ctr Vasc Anomalies, B-1200 Brussels, Belgium

[3] Harvard Univ, Sch Med, Childrens Hosp, Div Plast Surg, Boston, MA USA

[4] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA

[5] Harvard Univ, Sch Dent Med, Harvard Forsyth Dept Oral Biol, Boston, MA 02115 USA

来源：

TRENDS IN CARDIOVASCULAR MEDICINE | 1998年 / 8卷 / 07期

关键词：

D O I：

10.1016/S1050-1738(98)00024-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Vascular anomalies comprise a heterogeneous group of disorders that ave divided into tumors (hemangiomas) and malformations. Recent advances in biomedical research provide insights into the molecular basis of these disorders and a deeper understanding of vascular morphogenesis. In the future, this emerging knowledge will contribute to novel ways to treat vascular anomalies and to regulate pathologic angiogenesis. (Trends Cardiovasc Med 1998;8:281-292) (C) 1998, Elsevier Science Inc.

引用

收藏

页码：281 / 292

页数：12

相关论文

共 100 条

[1] Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) [J].

Achen, MG ;

Jeltsch, M ;

Kukk, E ;

Mäkinen, T ;

Vitali, A ;

Wilks, AF ;

Alitalo, K ;

Stacker, SA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :548-553

[2]

AELVOET GE, 1992, BRIT J DERMATOL, V126, P603

[3] NATURE AND EVOLUTION OF PORT WINE STAINS - COMPUTER-ASSISTED STUDY [J].

BARSKY, SH ;

ROSEN, S ;

GEER, DE ;

NOE, JM .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1980, 74 (03) :154-157

[4]

BEAN WB, 1958, VASCULAR SPIDERS REL

[5] Mapping of a major genetic modifier of embryonic lethality in TGF beta 1 knockout mice [J].

Bonyadi, M ;

Rusholme, SAB ;

Cousins, FM ;

Su, HC ;

Biron, CA ;

Farrall, M ;

Akhurst, RJ .

NATURE GENETICS, 1997, 15 (02) :207-211

[6] Congenital hemangioma: Evidence of accelerated involution [J].

Boon, LM ;

Enjolras, O ;

Mulliken, JB .

JOURNAL OF PEDIATRICS, 1996, 128 (03) :329-335

[7] Hepatic vascular anomalies in infancy: A twenty-seven-year experience [J].

Boon, LM ;

Burrows, PE ;

Paltiel, HJ ;

Lund, DP ;

Ezekowitz, RAB ;

Folkman, J ;

Mulliken, JB .

JOURNAL OF PEDIATRICS, 1996, 129 (03) :346-354

[8] ASSIGNMENT OF A LOCUS FOR DOMINANTLY INHERITED VENOUS MALFORMATIONS TO CHROMOSOME 9P [J].

BOON, LM ;

MULLIKEN, JB ;

VIKKULA, M ;

WATKINS, H ;

SEIDMAN, J ;

OLSEN, BR ;

WARMAN, ML .

HUMAN MOLECULAR GENETICS, 1994, 3 (09) :1583-1587

[9] EARLY 2ND-TRIMESTER SONOGRAPHIC APPEARANCE OF OCCIPITAL HEMANGIOMA SIMULATING ENCEPHALOCELE [J].

BRONSHTEIN, M ;

BARHAVA, I ;

BLUMENFELD, Z .

PRENATAL DIAGNOSIS, 1992, 12 (08) :695-698

[10] INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS [J].

BROOKS, PC ;

MONTGOMERY, AMP ;

ROSENFELD, M ;

REISFELD, RA ;

HU, TH ;

KLIER, G ;

CHERESH, DA .

CELL, 1994, 79 (07) :1157-1164

← 1 2 3 4 5 6 7 8 9 10 →